Search research articles
Contact Us
Filters
Showing results (81-90 of 116) with videos related to
Page
of 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1993
Prognostic significance of Ki-67 immunostaining in nonmetastatic renal cell carcinoma
W T de Riese, W N Crabtree, E P Allhoff, et al.
Cancer Biotherapy
|
January 1, 1993
Clinical and preclinical evaluation of recombinant PEG-IL-2 in human
T Menzel, A Schomburg, A Körfer, et al.
Acta Haematologica
|
January 1, 1990
Immunophenotypic analysis of lymphocytes and myeloma cells in patients with multiple myeloma
C Shimazaki, J Fried, A G Perez, et al.
Journal of Cutaneous Pathology
|
October 1, 1992
Analysis of the 14;18 translocation in cutaneous lymphomas using the polymerase chain reaction
M Volkenandt, L Cerroni, E Rieger, et al.
Bone Marrow Transplantation
|
August 1, 1992
Autologous bone marrow transplantation for acute myelogenous leukemia using 4-hydroperoxycyclophosphamide and VP-16 purged bone marrow
S Gulati, L Acaba, J Yahalom, et al.
British Journal of Cancer
|
January 1, 1997
Elevated serum levels of S100 and survival in metastatic malignant melanoma
J Buer, M Probst, A Franzke, et al.
Acta Haematologica
|
January 1, 1989
Immunophenotypic demonstration of two natural killer surface markers, H25 and H366, on fresh human leukemic cells
A Körfer, H Kirchner, C Schneekloth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 1999
Autoimmunity resulting from cytokine treatment predicts long-term survival in patients with metastatic renal cell cancer
A Franzke, D Peest, M Probst-Kepper, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 1, 1993
Expansion of peripheral blood natural killer cells correlates with clinical outcome in cancer patients receiving recombinant subcutaneous interleukin-2 and interferon-alpha-2
J Atzpodien, H Kirchner, A Körfer, et al.
Oncology
|
January 1, 1988
Ewing's sarcoma: ex vivo sensitivity towards natural and lymphokine-activated killing
J Atzpodien, S C Gulati, C Shimazaki, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 116) with videos related to
Sort By:
Page
of 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1993
Prognostic significance of Ki-67 immunostaining in nonmetastatic renal cell carcinoma
W T de Riese, W N Crabtree, E P Allhoff, et al.
Cancer Biotherapy
|
January 1, 1993
Clinical and preclinical evaluation of recombinant PEG-IL-2 in human
T Menzel, A Schomburg, A Körfer, et al.
Acta Haematologica
|
January 1, 1990
Immunophenotypic analysis of lymphocytes and myeloma cells in patients with multiple myeloma
C Shimazaki, J Fried, A G Perez, et al.
Journal of Cutaneous Pathology
|
October 1, 1992
Analysis of the 14;18 translocation in cutaneous lymphomas using the polymerase chain reaction
M Volkenandt, L Cerroni, E Rieger, et al.
Bone Marrow Transplantation
|
August 1, 1992
Autologous bone marrow transplantation for acute myelogenous leukemia using 4-hydroperoxycyclophosphamide and VP-16 purged bone marrow
S Gulati, L Acaba, J Yahalom, et al.
British Journal of Cancer
|
January 1, 1997
Elevated serum levels of S100 and survival in metastatic malignant melanoma
J Buer, M Probst, A Franzke, et al.
Acta Haematologica
|
January 1, 1989
Immunophenotypic demonstration of two natural killer surface markers, H25 and H366, on fresh human leukemic cells
A Körfer, H Kirchner, C Schneekloth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 1999
Autoimmunity resulting from cytokine treatment predicts long-term survival in patients with metastatic renal cell cancer
A Franzke, D Peest, M Probst-Kepper, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 1, 1993
Expansion of peripheral blood natural killer cells correlates with clinical outcome in cancer patients receiving recombinant subcutaneous interleukin-2 and interferon-alpha-2
J Atzpodien, H Kirchner, A Körfer, et al.
Oncology
|
January 1, 1988
Ewing's sarcoma: ex vivo sensitivity towards natural and lymphokine-activated killing
J Atzpodien, S C Gulati, C Shimazaki, et al.
Page
of 12